CDT Equity Welcomes Interim U.S. Policy Supporting Compounded Peptide Access

Bitget2026/10/30 12:33

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

CDT Equity today welcomed a US peptide compounding policy as supportive of its investment in Pep'd, a US peptide and telehealth company.
The HHS policy limits enforcement against qualifying providers compounding six specified peptides, subject to regulatory conditions.
CEO James Bligh called the policy a positive development for the investment, noting it remains interim; the covered peptides lack FDA approval.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CDT Equity Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610300832PRIMZONEFULLFEED9856887) on October 30, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

CDT Equity Welcomes Interim U.S. Policy Supporting Compounded Peptide Access

You may also like

Crypto prices